These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1791586)

  • 1. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
    Oddens BJ
    Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
    Moller SE; Moller BM; Olesen M; Fjalland B
    Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of combined oral contraceptive preparations.
    Singh BM; Nutter SA; Nattrass M
    Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study.
    Hamstra DA; de Kloet ER; de Rover M; Van der Does W
    J Psychosom Res; 2017 Dec; 103():119-126. PubMed ID: 29167038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of relaxin during the menstrual cycle and oral contraceptive use.
    Wreje U; Kristiansson P; Aberg H; Byström B; von Schoultz B
    Gynecol Obstet Invest; 1995; 39(3):197-200. PubMed ID: 7789917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol use, negative mood states, and menstrual cycle phases.
    Sutker PB; Libet JM; Allain AN; Randall CL
    Alcohol Clin Exp Res; 1983; 7(3):327-31. PubMed ID: 6353985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To what extent do oral contraceptives influence mood and affect?
    Oinonen KA; Mazmanian D
    J Affect Disord; 2002 Aug; 70(3):229-40. PubMed ID: 12128235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral contraceptives and some psychological factors on the menstrual experience.
    Harding CM; Vail C; Brown R
    J Biosoc Sci; 1985 Jul; 17(3):291-304. PubMed ID: 4040913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
    Heintz B; Schmauder C; Witte K; Breuer I; Baltzer K; Sieberth HG; Lemmer B
    J Hypertens; 1996 Mar; 14(3):333-9. PubMed ID: 8723987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
    den Tonkelaar I; Oddens BJ
    Contraception; 1999 Jun; 59(6):357-62. PubMed ID: 10518229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.
    Rosenberg MJ; Waugh MS; Meehan TE
    Contraception; 1995 May; 51(5):283-8. PubMed ID: 7628201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric complications of progesterone and oral contraceptives.
    Glick ID; Bennett SE
    J Clin Psychopharmacol; 1981 Nov; 1(6):350-67. PubMed ID: 7037875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eating disorder pathology and menstrual cycle fluctuations in eating variables in oral contraceptive users and non-users.
    McVay MA; Copeland AL; Geiselman PJ
    Eat Behav; 2011 Jan; 12(1):49-55. PubMed ID: 21184973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?
    Crowley T; Horner P; Hughes A; Berry J; Paul I; Caul O
    Int J STD AIDS; 1997 Jan; 8(1):25-31. PubMed ID: 9043977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.